Qing Sarah Yuan
Directeur Technique/Scientifique/R&D chez SIGILON THERAPEUTICS, INC.
Postes actifs de Qing Sarah Yuan
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| SIGILON THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 07/03/2022 | - |
Historique de carrière de Qing Sarah Yuan
Anciens postes connus de Qing Sarah Yuan
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| BIOVERATIV INC | Corporate Officer/Principal | 01/01/2017 | 01/01/2019 |
| 2SEVENTY BIO, INC. | Corporate Officer/Principal | - | - |
Formation de Qing Sarah Yuan
| University of Wisconsin | Doctorate Degree |
| University of California, Berkeley | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 6 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| SIGILON THERAPEUTICS, INC. | Health Technology |
| 2SEVENTY BIO, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Bioverativ, Inc.
 Bioverativ, Inc. BiotechnologyHealth Technology Bioverativ, Inc. is a global biopharmaceutical company, focused on discovery, research, development and commercialization of therapies for the treatment of blood diseases including hemophilia. The company is headquartered in Cambridge, MA. | Health Technology |
- Bourse
- Insiders
- Qing Sarah Yuan
- Expérience
